BioSpace News Archive

TRCA-301E trial is the first, long-term, randomized, multicenter, blinded, placebo-controlled trial to evaluate the treatment of metabolic acidosis in patients with CKD

Springfield Clinic implemented 14 CARESTREAM DRX-Evolution Plus Systems, two CARESTREAM DRX-Ascend Systems and one CARESTREAM DRX-1 System to deliver high-quality imaging for its patients.

Companies make commitment to raise the quality of life of pets and the heroes who love them.

Civica’s MDM technology offers a complete, accurate view of patient records, providing the clean, robust data necessary to enable healthcare innovators to power their predictive analytics and AI technology.

The webcast will be archived and accessible through July 24, 2020.

ClearBalance Honors CentraCare Health and MaineGeneral Health for Improved Revenue Cycle and Patient Satisfaction Metrics [25-June-2019] SAN DIEGO , June 25, 2019 /PRNewswire/ -- CentraCare Health in Minnesota and MaineGeneral Health in Maine have been named 2019 Patient Financing Top Performers by patient financing service provider ClearBalance ® in conjunction

Third patent covers using artificial intelligence to identify actionable insights from doctor, nurse and staff feedback to improve quality and reduce turnover

School for the visually impaired invests in the Clorox® Total 360® System to protect students and staff from easily contracted germs and viruses

Frontier Medicines today announced the closing of a Series A Preferred Stock financing round of $67 million led by Deerfield Management, Droia Oncology Ventures and MPM Capital, with participation from DCVC Bio (an affiliated fund of DCVC), RA Capital Management and other investors.

The transaction is subject to regulatory review and anticipated to close before the end of 2019.